Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 144692-85-3 | MDL No. : | MFCD29056530 |
Formula : | C6Cl2N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LHZDZLPHWGVCCB-UHFFFAOYSA-N |
M.W : | 218.98 | Pubchem ID : | 71345867 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.8 |
TPSA : | 69.15 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.4 cm/s |
Log Po/w (iLOGP) : | 0.43 |
Log Po/w (XLOGP3) : | 1.74 |
Log Po/w (WLOGP) : | 1.09 |
Log Po/w (MLOGP) : | 0.51 |
Log Po/w (SILICOS-IT) : | 2.2 |
Consensus Log Po/w : | 1.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.64 |
Solubility : | 0.507 mg/ml ; 0.00232 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.81 |
Solubility : | 0.34 mg/ml ; 0.00155 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.96 |
Solubility : | 0.24 mg/ml ; 0.00109 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.1 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1166831-45-3 ]
Methyl 6-chloro-3-methylpyrazine-2-carboxylate
Similarity: 0.91
[ 23611-75-8 ]
Methyl 6-chloropyrazine-2-carboxylate
Similarity: 0.86
[ 33332-25-1 ]
Methyl 5-chloropyrazine-2-carboxylate
Similarity: 0.86
[ 59715-45-6 ]
5,6-Dichloropyrazine-2,3-dicarboxylic acid
Similarity: 0.85
[ 76537-42-3 ]
5,6-Dichloropyrazine-2-carboxylic acid
Similarity: 0.80
[ 699-98-9 ]
2,3-Pyridinedicarboxylicanhydride
Similarity: 0.55
[ 1166831-45-3 ]
Methyl 6-chloro-3-methylpyrazine-2-carboxylate
Similarity: 0.91
[ 23611-75-8 ]
Methyl 6-chloropyrazine-2-carboxylate
Similarity: 0.86
[ 33332-25-1 ]
Methyl 5-chloropyrazine-2-carboxylate
Similarity: 0.86
[ 1458-18-0 ]
Methyl 3-amino-5,6-dichloropyrazine-2-carboxylate
Similarity: 0.80
[ 1458-03-3 ]
Methyl 3-amino-6-chloropyrazine-2-carboxylate
Similarity: 0.77
[ 699-98-9 ]
2,3-Pyridinedicarboxylicanhydride
Similarity: 0.55
[ 15783-48-9 ]
2,4-Dichlorofuro[3,4-d]pyrimidin-7(5H)-one
Similarity: 0.54
[ 850349-42-7 ]
Methyl imidazo[1,2-a]pyrazine-8-carboxylate
Similarity: 0.53